Chang Wang

A village doctor-led multifaceted intervention for blood pressure control in rural China: an open, cluster randomised trial

Y. Wang, J. Mu, Zhaoqing Sun, 2022, The Lancet.

Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial

H. Liu, J. Mu, Zhaoqing Sun, 2023, The Lancet.

Prevalence and prognosis of atrial fibrillation in a hypertensive population: A prospective cohort study

Yingxian Sun, Z. Du, Ning Ye, 2023, Journal of clinical hypertension.

Use of the Vascular Overload Index to Predict Cardiovascular Disease in a Rural Population of China

Yingxian Sun, D. Geng, Chuning Shi, 2022, BioMed research international.

Hyperlipidemia and hypertension have synergistic interaction on ischemic stroke: insights from a general population survey in China

Yingxian Sun, Z. Du, Ning Ye, 2022, BMC Cardiovascular Disorders.

Construction of a risk assessment model of cardiovascular disease in a rural Chinese hypertensive population based on lasso‐Cox analysis

Guangxiao Li, Yingxian Sun, Nanxiang Ouyang, 2021, Journal of clinical hypertension.

Using the Atherogenic Index of Plasma to Estimate the Prevalence of Ischemic Stroke within a General Population in a Rural Area of China

Yingxian Sun, Z. Du, Ning Ye, 2020, BioMed research international.

Intensive blood pressure control in isolated systolic hypertension: a post hoc analysis of a cluster randomized trial

Ning Ye, Nanxiang Ouyang, Chang Wang, 2024, The Lancet regional health. Western Pacific.